4-nitro-3-dimethylaminopropiophenone has been researched along with Diabetes Mellitus, Adult-Onset in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeJonckheere, M; Griauzde, DH; Isaman, DJM; Krinock, J; O'Brien, A; Richardson, CR; Saslow, LR; Shopinski, S; Vanias, K; Yancy, WS | 1 |
| Bower, P; Cotterill, S; Heller, S; Kontopantelis, E; Mcmanus, E; Meacock, R; Ravindrarajah, R; Reeves, D; Soiland-Reyes, C; Sutton, M; Whittaker, W | 1 |
| Calderón-Larrañaga, S; Clinch, M; Dostal, I; Eto, F; Finer, S; Greenhalgh, T; Robson, J | 1 |
| Levkoff, SE; Nicklas, JM; Ritchie, ND; Seely, EW | 1 |
| Herman, WH; Joiner, KL; McEwen, LN; Villatoro, C | 1 |
1 trial(s) available for 4-nitro-3-dimethylaminopropiophenone and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Life Style; Lipids; Nitro Compounds; Prediabetic State; Propiophenones; Randomized Controlled Trials as Topic; Weight Loss | 2022 |
4 other study(ies) available for 4-nitro-3-dimethylaminopropiophenone and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysis.
Topics: Adult; Child, Preschool; Cohort Studies; Diabetes Mellitus, Type 2; England; Humans; Hyperglycemia; Referral and Consultation; State Medicine | 2023 |
Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation.
Topics: Diabetes Mellitus, Type 2; Humans; London; Program Evaluation; Referral and Consultation | 2023 |
Effectiveness of the National Diabetes Prevention Program After Gestational Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Humans; Life Style; Pregnancy; Weight Loss | 2023 |
Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Nitro Compounds; Prediabetic State | 2023 |